Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 512

1.

Stage-dependent BDNF serum concentrations in Alzheimer's disease.

Laske C, Stransky E, Leyhe T, Eschweiler GW, Wittorf A, Richartz E, Bartels M, Buchkremer G, Schott K.

J Neural Transm. 2006 Sep;113(9):1217-24. Epub 2005 Dec 16.

PMID:
16362629
[PubMed - indexed for MEDLINE]
2.

BDNF serum and CSF concentrations in Alzheimer's disease, normal pressure hydrocephalus and healthy controls.

Laske C, Stransky E, Leyhe T, Eschweiler GW, Maetzler W, Wittorf A, Soekadar S, Richartz E, Koehler N, Bartels M, Buchkremer G, Schott K.

J Psychiatr Res. 2007 Aug;41(5):387-94. Epub 2006 Mar 22.

PMID:
16554070
[PubMed - indexed for MEDLINE]
3.

Alzheimer's disease (AD) and Mild Cognitive Impairment (MCI) patients are characterized by increased BDNF serum levels.

Angelucci F, Spalletta G, di Iulio F, Ciaramella A, Salani F, Colantoni L, Varsi AE, Gianni W, Sancesario G, Caltagirone C, Bossù P.

Curr Alzheimer Res. 2010 Feb;7(1):15-20.

PMID:
20205668
[PubMed - indexed for MEDLINE]
4.

Increase of BDNF serum concentration during donepezil treatment of patients with early Alzheimer's disease.

Leyhe T, Stransky E, Eschweiler GW, Buchkremer G, Laske C.

Eur Arch Psychiatry Clin Neurosci. 2008 Mar;258(2):124-8. Epub 2007 Nov 7.

PMID:
17990049
[PubMed - indexed for MEDLINE]
5.

Precursor form of brain-derived neurotrophic factor and mature brain-derived neurotrophic factor are decreased in the pre-clinical stages of Alzheimer's disease.

Peng S, Wuu J, Mufson EJ, Fahnestock M.

J Neurochem. 2005 Jun;93(6):1412-21.

PMID:
15935057
[PubMed - indexed for MEDLINE]
6.

Serum BDNF, TNF-alpha and IL-1beta levels in dementia patients: comparison between Alzheimer's disease and vascular dementia.

Yasutake C, Kuroda K, Yanagawa T, Okamura T, Yoneda H.

Eur Arch Psychiatry Clin Neurosci. 2006 Oct;256(7):402-6. Epub 2006 Jun 16.

PMID:
16783499
[PubMed - indexed for MEDLINE]
7.

Association of platelet-derived soluble glycoprotein VI in plasma with Alzheimer's disease.

Laske C, Leyhe T, Stransky E, Eschweiler GW, Bueltmann A, Langer H, Stellos K, Gawaz M.

J Psychiatr Res. 2008 Jul;42(9):746-51. Epub 2007 Sep 12.

PMID:
17854831
[PubMed - indexed for MEDLINE]
8.

Higher BDNF serum levels predict slower cognitive decline in Alzheimer's disease patients.

Laske C, Stellos K, Hoffmann N, Stransky E, Straten G, Eschweiler GW, Leyhe T.

Int J Neuropsychopharmacol. 2011 Apr;14(3):399-404. doi: 10.1017/S1461145710001008. Epub 2010 Sep 22.

PMID:
20860877
[PubMed - indexed for MEDLINE]
9.

Association study of the decreased serum BDNF concentrations in amnestic mild cognitive impairment and the Val66Met polymorphism in Chinese Han.

Yu H, Zhang Z, Shi Y, Bai F, Xie C, Qian Y, Yuan Y, Deng L.

J Clin Psychiatry. 2008 Jul;69(7):1104-11.

PMID:
18505307
[PubMed - indexed for MEDLINE]
10.
11.

Neuropsychological and behavioural correlates of CSF biomarkers in dementia.

Engelborghs S, Maertens K, Vloeberghs E, Aerts T, Somers N, Mariën P, De Deyn PP.

Neurochem Int. 2006 Mar;48(4):286-95. Epub 2006 Jan 24.

PMID:
16434124
[PubMed - indexed for MEDLINE]
12.

Inverse association of cortisol serum levels with T-tau, P-tau 181 and P-tau 231 peptide levels and T-tau/Abeta 1-42 ratios in CSF in patients with mild Alzheimer's disease dementia.

Laske C, Stransky E, Fritsche A, Eschweiler GW, Leyhe T.

Eur Arch Psychiatry Clin Neurosci. 2009 Mar;259(2):80-5. doi: 10.1007/s00406-008-0838-3. Epub 2008 Sep 19.

PMID:
18806919
[PubMed - indexed for MEDLINE]
14.

CSF markers in Alzheimer disease patients are not related to the different degree of cognitive impairment.

Stefani A, Martorana A, Bernardini S, Panella M, Mercati F, Orlacchio A, Pierantozzi M.

J Neurol Sci. 2006 Dec 21;251(1-2):124-8. Epub 2006 Nov 9.

PMID:
17097109
[PubMed - indexed for MEDLINE]
15.

Two-year follow-up of amyloid deposition in patients with Alzheimer's disease.

Engler H, Forsberg A, Almkvist O, Blomquist G, Larsson E, Savitcheva I, Wall A, Ringheim A, Långström B, Nordberg A.

Brain. 2006 Nov;129(Pt 11):2856-66. Epub 2006 Jul 19.

PMID:
16854944
[PubMed - indexed for MEDLINE]
Free Article
16.

Increase of BDNF serum concentration in lithium treated patients with early Alzheimer's disease.

Leyhe T, Eschweiler GW, Stransky E, Gasser T, Annas P, Basun H, Laske C.

J Alzheimers Dis. 2009;16(3):649-56. doi: 10.3233/JAD-2009-1004.

PMID:
19276559
[PubMed - indexed for MEDLINE]
17.

Anomalously phosphorylated tau and Abeta fragments in the CSF correlates with cognitive impairment in MCI subjects.

Maccioni RB, Lavados M, Guillón M, Mujica C, Bosch R, Farías G, Fuentes P.

Neurobiol Aging. 2006 Feb;27(2):237-44. Epub 2005 Apr 7.

PMID:
16399209
[PubMed - indexed for MEDLINE]
18.

BDNF is a novel marker of cognitive function in ageing women: the DR's EXTRA Study.

Komulainen P, Pedersen M, Hänninen T, Bruunsgaard H, Lakka TA, Kivipelto M, Hassinen M, Rauramaa TH, Pedersen BK, Rauramaa R.

Neurobiol Learn Mem. 2008 Nov;90(4):596-603. doi: 10.1016/j.nlm.2008.07.014. Epub 2008 Sep 6.

PMID:
18707012
[PubMed - indexed for MEDLINE]
19.

Clinicopathologic correlations of soluble amyloid beta-protein precursor in cerebrospinal fluid in patients with Alzheimer disease and controls.

Peskind ER, Leverenz J, Farlow MR, Ito RK, Provow SA, Siegel RS, Cleveland M, Morgan CH, Pandian MR, Corbin S, Nochlin D, Schellenberg GD, Raskind MA, Wagner SL.

Alzheimer Dis Assoc Disord. 1997 Dec;11(4):201-6.

PMID:
9437437
[PubMed - indexed for MEDLINE]
20.

Role of BDNF Val66Met functional polymorphism in Alzheimer's disease-related depression.

Borroni B, Archetti S, Costanzi C, Grassi M, Ferrari M, Radeghieri A, Caimi L, Caltagirone C, Di Luca M, Padovani A; ITINAD Working Group.

Neurobiol Aging. 2009 Sep;30(9):1406-12. doi: 10.1016/j.neurobiolaging.2007.11.023. Epub 2008 Jan 7.

PMID:
18179845
[PubMed - indexed for MEDLINE]
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk